| Date: |
20-04-2021
|
| Notification No: |
Notification No. 27/2021–Customs
|
| Issuing Authority: |
Indian Customs
|
| Type: |
Tariff
|
| File No: |
[F.No. 354/3/2021-TRU] |
| Subject: |
Seeks to exempt customs duty on import of Remdesivir injection, Remdesivir API and Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir, up to 31st October, 2021.
|
|
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(DEPARTMENT OF REVENUE)
Notification No. 27/2021–Customs
New Delhi, the 20th April, 2021
G.S.R. (E).- In exercise of the powers conferred
by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the
Central Government, on being satisfied that it is necessary in the public
interest so to do, hereby exempts the goods of the description specified in
column (3) of the Table below, falling within the Chapter, heading, sub–heading
or tariff item of the First Schedule to the Customs Tariff Act, 1975 (51 of
1975) specified in column (2) of the said Table, when imported into India, from
the whole of the duty of customs leviable thereon under the said First Schedule,
namely-
Table
| S.No. |
Chapter or heading or sub–heading or tariff item |
Description of goods |
| (1) |
(2) |
(3) |
| 1. |
29 |
Remdesivir Active Pharmaceutical Ingredients. |
| 2. |
29 |
Beta Cyclodextrin (SBEBCD) used in manufacture of Remdesivir,
subject to the condition that the importer follows the procedure set out
in the Customs (Import of Goods at Concessional Rate of Duty) Rules,
2017. |
| 3. |
30 |
Injection Remdesivir. |
2. This notification shall remain in force upto
and inclusive of the 31st October, 2021.
[F.No. 354/3/2021-TRU]
(Gaurav Singh)
Deputy Secretary to the Government of India
|
|
|